×
S&P 500   3,754.47 (-1.85%)
DOW   30,410.05 (-2.21%)
QQQ   280.62 (-0.54%)
AAPL   138.69 (-0.17%)
MSFT   256.93 (-1.02%)
META   161.54 (+0.94%)
GOOGL   2,170.42 (-0.20%)
AMZN   110.10 (+0.49%)
TSLA   666.49 (-2.24%)
NVDA   146.45 (+0.84%)
NIO   21.24 (-0.56%)
BABA   115.50 (-0.43%)
AMD   73.79 (+0.16%)
MU   55.15 (+2.80%)
CGC   2.69 (-4.27%)
T   20.91 (-1.88%)
GE   60.42 (-4.91%)
F   10.79 (-4.68%)
DIS   94.13 (-2.09%)
AMC   12.97 (-4.14%)
PFE   50.79 (-2.91%)
PYPL   72.17 (+1.08%)
NFLX   179.16 (-0.44%)
S&P 500   3,754.47 (-1.85%)
DOW   30,410.05 (-2.21%)
QQQ   280.62 (-0.54%)
AAPL   138.69 (-0.17%)
MSFT   256.93 (-1.02%)
META   161.54 (+0.94%)
GOOGL   2,170.42 (-0.20%)
AMZN   110.10 (+0.49%)
TSLA   666.49 (-2.24%)
NVDA   146.45 (+0.84%)
NIO   21.24 (-0.56%)
BABA   115.50 (-0.43%)
AMD   73.79 (+0.16%)
MU   55.15 (+2.80%)
CGC   2.69 (-4.27%)
T   20.91 (-1.88%)
GE   60.42 (-4.91%)
F   10.79 (-4.68%)
DIS   94.13 (-2.09%)
AMC   12.97 (-4.14%)
PFE   50.79 (-2.91%)
PYPL   72.17 (+1.08%)
NFLX   179.16 (-0.44%)
S&P 500   3,754.47 (-1.85%)
DOW   30,410.05 (-2.21%)
QQQ   280.62 (-0.54%)
AAPL   138.69 (-0.17%)
MSFT   256.93 (-1.02%)
META   161.54 (+0.94%)
GOOGL   2,170.42 (-0.20%)
AMZN   110.10 (+0.49%)
TSLA   666.49 (-2.24%)
NVDA   146.45 (+0.84%)
NIO   21.24 (-0.56%)
BABA   115.50 (-0.43%)
AMD   73.79 (+0.16%)
MU   55.15 (+2.80%)
CGC   2.69 (-4.27%)
T   20.91 (-1.88%)
GE   60.42 (-4.91%)
F   10.79 (-4.68%)
DIS   94.13 (-2.09%)
AMC   12.97 (-4.14%)
PFE   50.79 (-2.91%)
PYPL   72.17 (+1.08%)
NFLX   179.16 (-0.44%)
S&P 500   3,754.47 (-1.85%)
DOW   30,410.05 (-2.21%)
QQQ   280.62 (-0.54%)
AAPL   138.69 (-0.17%)
MSFT   256.93 (-1.02%)
META   161.54 (+0.94%)
GOOGL   2,170.42 (-0.20%)
AMZN   110.10 (+0.49%)
TSLA   666.49 (-2.24%)
NVDA   146.45 (+0.84%)
NIO   21.24 (-0.56%)
BABA   115.50 (-0.43%)
AMD   73.79 (+0.16%)
MU   55.15 (+2.80%)
CGC   2.69 (-4.27%)
T   20.91 (-1.88%)
GE   60.42 (-4.91%)
F   10.79 (-4.68%)
DIS   94.13 (-2.09%)
AMC   12.97 (-4.14%)
PFE   50.79 (-2.91%)
PYPL   72.17 (+1.08%)
NFLX   179.16 (-0.44%)
NASDAQ:UTMD

Utah Medical Products Stock Forecast, Price & News

$84.00
-0.74 (-0.87%)
(As of 07/5/2022 10:29 AM ET)
Add
Compare
Today's Range
$84.00
$84.00
50-Day Range
$81.49
$88.98
52-Week Range
$80.31
$133.87
Volume
6 shs
Average Volume
13,081 shs
Market Capitalization
$305.76 million
P/E Ratio
20.10
Dividend Yield
1.37%
Price Target
N/A

Utah Medical Products MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Bearish
1.46% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-0.79
Upright™ Environmental Score
News Sentiment
0.94mentions of Utah Medical Products in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$170,400 Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

1.67 out of 5 stars

Medical Sector

768th out of 1,428 stocks

Surgical & Medical Instruments Industry

84th out of 138 stocks

30 days | 90 days | 365 days | Advanced Chart

Receive UTMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Utah Medical Products and its competitors with MarketBeat's FREE daily newsletter.

Utah Medical Products logo

About Utah Medical Products (NASDAQ:UTMD) Stock

Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO umbilical vessel catheters; DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; FINESSE+ generators; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS endoscopic irrigation devices; suprapubic catheterization; LIBERTY urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN tool to manipulate the uterus in laparoscopic procedures. Additionally, the company offers DELTRAN, a disposable pressure transducer; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices through direct customer service and sales force, independent consultants, and manufacturer representatives. The company was incorporated in 1978 and is headquartered in Midvale, Utah.

UTMD Stock News Headlines

27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%! When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Utah Medical Products declares $0.29 dividend
27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%! When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Utah Medical Products raises dividend by 2% to $0.29
Utah Medical Products declares $2.00 special dividend
See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:UTMD
CUSIP
91748810
Employees
178
Year Founded
N/A

Company Calendar

Last Earnings
4/26/2022
Ex-Dividend for 7/6 Dividend
6/16/2022
Today
7/05/2022
Dividend Payable
7/06/2022
Next Earnings (Estimated)
7/28/2022
Fiscal Year End
12/31/2022

Profitability

Net Income
$14.79 million
Pretax Margin
39.06%

Debt

Sales & Book Value

Annual Sales
$49.05 million
Cash Flow
$6.10 per share
Book Value
$29.34 per share

Miscellaneous

Free Float
3,404,000
Market Cap
$305.76 million
Optionable
Not Optionable
Beta
0.24














Utah Medical Products Frequently Asked Questions

How has Utah Medical Products' stock performed in 2022?

Utah Medical Products' stock was trading at $100.00 on January 1st, 2022. Since then, UTMD stock has decreased by 16.0% and is now trading at $84.00.
View the best growth stocks for 2022 here
.

When is Utah Medical Products' next earnings date?

Utah Medical Products is scheduled to release its next quarterly earnings announcement on Thursday, July 28th 2022.
View our earnings forecast for Utah Medical Products
.

How were Utah Medical Products' earnings last quarter?

Utah Medical Products, Inc. (NASDAQ:UTMD) posted its quarterly earnings data on Tuesday, April, 26th. The medical instruments supplier reported $0.96 EPS for the quarter. The medical instruments supplier had revenue of $12.32 million for the quarter. Utah Medical Products had a net margin of 30.34% and a trailing twelve-month return on equity of 14.14%.
View Utah Medical Products' earnings history
.

How often does Utah Medical Products pay dividends? What is the dividend yield for Utah Medical Products?

Utah Medical Products declared a quarterly dividend on Tuesday, May 10th. Shareholders of record on Friday, June 17th will be given a dividend of $0.29 per share on Wednesday, July 6th. This represents a $1.16 dividend on an annualized basis and a yield of 1.38%. The ex-dividend date of this dividend is Thursday, June 16th.
View Utah Medical Products' dividend history
.

Is Utah Medical Products a good dividend stock?

Utah Medical Products(NASDAQ:UTMD) pays an annual dividend of $1.16 per share and currently has a dividend yield of 1.37%. Utah Medical Products does not yet have a strong track record of dividend growth. The dividend payout ratio of Utah Medical Products is 27.75%. This payout ratio is at a healthy, sustainable level, below 75%.
View Utah Medical Products' dividend history.

Who are Utah Medical Products' key executives?

Utah Medical Products' management team includes the following people:
  • Mr. Kevin L. Cornwell, Chairman, CEO, Pres & Sec. (Age 75, Pay $494.21k)
  • Mr. Brian L. Koopman, Principal Financial Officer, Accounting Mang. & Controller (Age 52, Pay $131.84k)
  • Mark L. Fox, VP of Marketing

What is Kevin L. Cornwell's approval rating as Utah Medical Products' CEO?

8 employees have rated Utah Medical Products CEO Kevin L. Cornwell on Glassdoor.com. Kevin L. Cornwell has an approval rating of 43% among Utah Medical Products' employees. This puts Kevin L. Cornwell in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Utah Medical Products own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Utah Medical Products investors own include Simon Property Group (SPG), Walt Disney (DIS), UnitedHealth Group (UNH), Intuitive Surgical (ISRG), Altria Group (MO), SEI Investments (SEIC), Trupanion (TRUP), Visa (V), Ventas (VTR) and (AAXN).

What is Utah Medical Products' stock symbol?

Utah Medical Products trades on the NASDAQ under the ticker symbol "UTMD."

How do I buy shares of Utah Medical Products?

Shares of UTMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Utah Medical Products' stock price today?

One share of UTMD stock can currently be purchased for approximately $84.00.

How much money does Utah Medical Products make?

Utah Medical Products (NASDAQ:UTMD) has a market capitalization of $305.76 million and generates $49.05 million in revenue each year. The medical instruments supplier earns $14.79 million in net income (profit) each year or $4.18 on an earnings per share basis.

How many employees does Utah Medical Products have?

Utah Medical Products employs 178 workers across the globe.

How can I contact Utah Medical Products?

Utah Medical Products' mailing address is 7043 South 300 West, Midvale UT, 84047. The official website for Utah Medical Products is www.utahmed.com. The medical instruments supplier can be reached via phone at (801) 566-1200 or via fax at 801-566-7305.

This page (NASDAQ:UTMD) was last updated on 7/5/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.